Discover
CNTB
Connect Biopharma Holdings Limited
2.39
2 x 1.78
2 x 3.03
bid
ask
+
0.01
0.42%
2 @ 04:00 AM
2.46 +0.07 (2.93%)
| Ytd | -15.25% | |
| 1y | 125.47% |
2.34
day range
2.51
1.02
52 week range
3.82
| Open | 2.45 | Prev Close | 2.38 | Low | 2.34 | High | 2.51 | Mkt Cap | 150.48M |
| Vol | 375.95K | Avg Vol | 318.82K | EPS | -1.15 | P/E | N/A | Forward P/E | -5.04 |
| Beta | -0.31 | Short Ratio | 1.93 | Inst. Own | 44.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-19 | 50-d Avg | 2.32 | 200-d Avg | 2.34 | 1yr Est | 7.00 |
CNTB News
benzinga.com
Piper Sandler Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price
Piper Sandler analyst Biren Amin initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with
benzinga.com
HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) w
benzinga.com
Connect Biopharma Completes Enrollment In Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibar
– On track to also complete enrollment in the Seabreeze STAT COPD study this month –– Expect to repo
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session